Work

Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.

Year: 2003

Type: article

Source: PubMed

Authors: Michael T Beck, Nian Y Chen, Karl J Franek, Wen Y Chen

Institution: Clemson University

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: IN VIVO STUDIES OF A PROLACTIN ANTAGONIST IN SCID MOUSE

OpenAlex ID: W1502515987

FWCI: 1.226

Cites: 37

Cited by: 36

Related to: 10